Brian Nowosielski

David Swenson, RPh, discussed drug shortage technology that his company is helping bring to community pharmacies across the country.

PBM expert Antonio Ciaccia, president of 3 Axis Advisors and CEO of 46brooklyn Research, discussed recent events in the pharmacy benefits industry and how it is moving toward PBM reform.

Antonio Ciaccia, President of 3 Axis Advisors, CEO of 46brooklyn Research, and pharmacy benefits expert, discussed his role in uncovering PBM practices and pharmacy consulting.

Researchers explored the current evidence regarding women’s reactions to biological therapies for treating atopic dermatitis during pregnancy.

David Swenson, RPh, Founder and CEO of ShortStop Rx, joined Drug Topics to discuss the CCT Rx Shortage Solutions technology and how it’s helping combat drug shortages in the US.

Approval comes from positive results in the MATINEE and METREX phase III trials, with data showing a significant reduction in annual rates of COPD exacerbations among patients.

Insulin delivery technology company Sequel Med Tech announced its future partnership with Abbott’s glucose-ketone sensor, which is currently under development.

During Viral Hepatitis Awareness Month, Jeff Goad, PharmD, MPH, joined Over the Counter to discuss hepatitis vaccines and the common trends pharmacists in this space should keep in mind.

Through a comprehensive review and meta-analysis, researchers identified the correlation between atopic dermatitis and dementia.

Researchers investigate annual medication costs for children and determine which of them would qualify for medication therapy management based on CMS thresholds.

Researchers aim to understand how deprescribing interventions impacted changes in inappropriate medication use or total prescription drugs among older, community-dwelling adults.

President of the National Foundation for Infectious Diseases, Jeff Goad, PharmD, MPH, discusses how pharmacists can help improve hepatitis A and B vaccine rates across the country.

In part 2 of our video series with drug market experts Luke Turnock, PhD, and Jenny Markell, we explored social media advertisements for prescription drugs and how they may impact patients.

Researchers estimate the cost-effectiveness of PCV24 in the older adult population compared with the currently accepted pneumococcal vaccine schedules in the US.

Researchers wanted to better understand prescribing patterns of pneumococcal vaccines for people living with HIV in a tertiary care hospital.

Researchers conduct a scoping review to update and determine what the best available options are for treating patients with skin-picking disorder.

In children aged 5 to 17 with skin disorders, researchers explore the risk of developing psychosocial comorbidities, sleep disturbances, and common related symptoms.

Jeff Goad, PharmD, MPH, discusses hesitancy for hepatitis vaccines and the necessary advice pharmacists can utilize to help patients manage these misconceptions.

Researchers conducted a clinical review detailing the intersection of dermatology and suicide, explaining why skin conditions lead to increased risk of poor mental health.

Drug Market experts joined Drug Topics to discuss the rise in direct-to-consumer drug advertising and what it means for patients around the world.

Jeff Goad, PharmD, MPH, discusses hepatitis viruses and the current vaccination schedules available for patients to stay protected.

Ronna Hauser, PharmD, Senior Vice President of Policy & Pharmacy Affairs at NCPA, provides insights into President Trump’s most recent executive order regarding manufacturer drug prices.

NBC News Medical Analyst Vin Gupta, MD, joins Drug Topics at NCPDP 2025 to discuss the technological evolution of the pharmacy profession.

Attorneys from The Phoenix Law Group joined Drug Topics at NCPDP 2025 to discuss the current state of pharmacy benefit manager reform and where it may end up in the near future.

The NCPDP’s Executive Vice President of Innovation & Standards joins Drug Topics to discuss how AI has been making itself known within the pharmacy profession.

Rick Sage, Executive Vice President of Innovation & Standards at NCPDP, discusses his role and how his team is using innovation to support the pharmacy profession.

Larry King, PharmD, joins Drug Topics at NCPDP 2025 to discuss pharmacy interoperability, changes in its regulations, and how technology will fall into place within the data infrastructure.

In part 3 of our interview with Vin Gupta, MD, he discusses pharmacists’ role in remote patient care amid a growing technological infrastructure.

In the second part of our interview with Miranda Rochol, she discusses challenges regarding digital prescription solutions and the financial burdens these solutions are designed for pharmacists to overcome.

In her expertise as a leader with the American Pharmacists Association, Brigid Groves, PharmD, MS, provides insights into her work with geographical information systems and maps.